These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10907156)

  • 1. [Successful management of systemic lupus erythematosus with IgM enriched immunoglobulins].
    Enk AH; Knop J
    Hautarzt; 2000 Jun; 51(6):416-8. PubMed ID: 10907156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
    Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
    Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin.
    Hundt M; Manger K; Dörner T; Grimbacher B; Kalden P; Rascu A; Weber D; Burmester GR; Peter HH; Kalden JR; Schmidt RE
    Rheumatology (Oxford); 2000 Nov; 39(11):1301-2. PubMed ID: 11085821
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin.
    Ilan Y; Naparstek Y
    Acta Haematol; 1993; 89(3):152-4. PubMed ID: 8362604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Off-label use of intravenous immunoglobulin therapy in the treatment of lupus myocarditis: Two case reports and literature review].
    Charhon N; Bernard C; Richard JC; Cordel N; Leboucher G; Broussolle C; Sève P
    Rev Med Interne; 2017 Mar; 38(3):204-209. PubMed ID: 27263120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy: modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus.
    Puddu P; De Pità O; Ruffelli M; Bellucci AM; Girardelli CR; Galeazzi M; Marcolongo R
    Arthritis Rheum; 1996 Apr; 39(4):704-5. PubMed ID: 8630125
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual presentation of systemic lupus erythematosus.
    Mahesh E; Madhyastha PR; Varma V; Gurudev KC; Gireesh MS; Bande SR
    Saudi J Kidney Dis Transpl; 2017; 28(3):653-656. PubMed ID: 28540909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
    Prior-Español Á; Martínez-Morillo M; Riveros-Frutos A; Olivé A
    Med Clin (Barc); 2015 Dec; 145(11):507-8. PubMed ID: 25858768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aggressive therapy of highly active systemic lupus erythematosus].
    Graninger W
    Acta Med Austriaca; 1996; 23(4):129-33. PubMed ID: 9036724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulin administration to a patient with systemic lupus erythematosus and pneumococcal septicemia].
    Maltbaek N; Harreby MS; Thøgersen B
    Ugeskr Laeger; 1994 Jul; 156(27):4039-41. PubMed ID: 8066901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus.
    Sherer Y; Levy Y; Shoenfeld Y
    Clin Rheumatol; 1999; 18(3):238-40. PubMed ID: 11206350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
    Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
    Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome.
    Vázquez-Sanabria IL; Mercado-Seda R; Varela-Rosario N; Vilá LM
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26202316
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus band test in uninvolved oral mucosa in systemic lupus erythematosus.
    Jonsson R; Nyberg G; Kristensson-Aas A; Westberg NG
    Acta Med Scand; 1983; 213(4):269-73. PubMed ID: 6351550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyvalent intravenous immunoglobulins in systemic lupus].
    Papo T
    Rev Med Interne; 1999; 20 Suppl 4():414s-418s. PubMed ID: 10522315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.